RT Journal Article
SR Electronic
T1 Morphological alternations of intracerebral arterial during middle age: a community cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.13.21263492
DO 10.1101/2021.09.13.21263492
A1 Zhang, Boyu
A1 Yang, Zidong
A1 Li, Jing
A1 Wang, Bei
A1 Shi, Huazheng
A1 Wang, He
A1 Li, Yuehua
YR 2021
UL http://medrxiv.org/content/early/2021/09/15/2021.09.13.21263492.abstract
AB Background Ample evidence has suggested that vascular modifications are associated with aging. To expand previous understanding of age-related vascular changes, we examined the association between aging and cerebrovascular morphologies.Methods 1176 participants aged 35 to 75 years recruited from Shanghai, China were included in this study. Cerebrovascular morphological features comprising arterial branch density, radius, and tortuosity were quantified using three-dimensional magnetic resonance angiography. Linear regression was used to examine the association between age and vasculature features.Results Age was found to be a significant predictor for cerebrovascular morphological alterations after adjusting for vascular risk factors. However, after dividing subjects into subgroups based on their age, aging was found to be significantly correlated with all three morphometric features only in the 45-54 subgroup after adjusting for the other vascular risk factors. Smoking gives rise to a more rapid age-related changes in vascular morphologies, while alcohol consumption could decelerate those age-related alterations.Conclusions Rapid alternations in all three morphological features assessed have been noticed to be associated with aging in the 45-54 subgroup, suggesting the potential importance of the 5th decade for early preservation method of vascular aging.Funding National Natural Science Foundation of China.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (No. 81971583, No. 81871329), National Key R&D Program of China (No. 2018YFC1312900), New developing and Frontier Technologies of Shanghai Shen Kang Hospital Development Center (No. SHDC12018117), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (No. 2016427), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01) and ZJLab.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board of the Sixth People's Hospital, Shanghai, China. All participants were voluntarily enrolled and provided written informed consent before data collection.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll data are available on reasonable request to corresponding authors.